NASDAQ100 Tests ATH – Key Decision Zone at 23170
New ATH Achieved:
NASDAQ100 recorded a new All-Time High (ATH), hitting our target at 23170 precisely as projected.
Currently, price is consolidating below 23170. Sustained rejection at this level could trigger a short-term bearish pullback toward 23010. A deeper correction may extend to 22900 or even 22815.
However, a clean breakout above 23170 would confirm bullish continuation, with the next target at 23350.
Key Levels
• Pivot: 23170
• Resistance: 23250 / 23350
• Support: 23010 / 22900 / 22815
Outlook:
• Bullish above 23170
• Bearish below 23170 (short-term pullback zone)
New ATH Achieved:
NASDAQ100 recorded a new All-Time High (ATH), hitting our target at 23170 precisely as projected.
Currently, price is consolidating below 23170. Sustained rejection at this level could trigger a short-term bearish pullback toward 23010. A deeper correction may extend to 22900 or even 22815.
However, a clean breakout above 23170 would confirm bullish continuation, with the next target at 23350.
Key Levels
• Pivot: 23170
• Resistance: 23250 / 23350
• Support: 23010 / 22900 / 22815
Outlook:
• Bullish above 23170
• Bearish below 23170 (short-term pullback zone)
Technical analyst focused on gold, indices, and forex.
Providing regular updates with structure, entry/exit clarity, and real-time outlooks.
More at: sroshmayi.com/
Providing regular updates with structure, entry/exit clarity, and real-time outlooks.
More at: sroshmayi.com/
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Technical analyst focused on gold, indices, and forex.
Providing regular updates with structure, entry/exit clarity, and real-time outlooks.
More at: sroshmayi.com/
Providing regular updates with structure, entry/exit clarity, and real-time outlooks.
More at: sroshmayi.com/
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.